Early clinical trial data show gene therapy reversing sickle cell anemia

After over a decade of preclinical research and development, a new gene therapy treatment for sickle cell anemia (SCA) is reversing disease symptoms in two adults and showing early potential for transportability to resource-challenged parts of the world where SCA is most common.

Leave a Reply

Your email address will not be published.